Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
46-60 of 2220 results
Heptares to buy G7 Therapeutics to expand GPCR capabilities
By PBR Staff Writer
Sosei Group's subsidiary Heptares Therapeutics has agreed to acquire Swiss drugmaker G7 Therapeutics for CHF12m ($11.8m).
Production & Manufacturing > Manufacturing > News
Takeda to establish dengue vaccine manufacturing facility in Germany
By PBR Staff Writer
Takeda Pharmaceutical is investing over €100m to build a new dengue vaccine manufacturing facility in Singen, Germany.
Production & Manufacturing > Manufacturing > News
West Pharmaceutical Services expands contract manufacturing capabilities in Ireland
West Pharmaceutical Services has completed a 60,000ft² expansion at its contract manufacturing facility near Mulhuddart, County Dublin, Ireland.
Production & Manufacturing > Manufacturing > News
Patheon agrees to buy Roche's API manufacturing plant in South Carolina
Patheon, a global provider of pharmaceutical development and manufacturing services, has agreed to acquire an active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc., an indirect, wholly owned subsidiary of Roche Holding Ltd.
Production & Manufacturing > Manufacturing > News
Johnson & Johnson in talks to buy Swiss drug maker Actelion
By PBR Staff Writer
Johnson & Johnson has approached Swiss drug maker Actelion Pharmaceuticals for a potential takeover.
Production & Manufacturing > Manufacturing > News
Neovacs partners with 3P Biopharmaceuticals to manufacture interferon alpha cytokine
Neovacs has partnered with 3P Biopharmaceuticals to manufacture interferon alpha (IFNα) cytokine.
Production & Manufacturing > Manufacturing > News
Sun Pharma to buy 85% stake in Russian pharmaceutical firm Biosintez
Sun Pharma has agreed to acquire 85.1% stake in JSC Biosintez, a Russian pharmaceutical firm engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region.
Production & Manufacturing > Manufacturing > News
Novartis acquires Selexys Pharmaceuticals in $665m deal
By PBR Staff Writer
Novartis has acquired Selexys Pharmaceuticals, an Oklahoma City based company specializing in hematologic and inflammatory disorders, in a deal worth about $665m.
Production & Manufacturing > Manufacturing > News
IV-administered Ganaxolone and Diazepam synergistically block seizures in animal model of SE
Marinus Pharmaceuticals presented preclinical data showing that the combination of its CNS-selective GABAA modulator ganaxolone and diazepam administered intravenously (IV) produced a synergistic effect in blocking pilocarpine-induced seizures in a benzodiazepine refractory model of status epilepticus (SE).
Production & Manufacturing > Manufacturing > News
Biocon, Mylan seek FDA approval for trastuzumab biosimilar
By PBR Staff Writer
Drug makers Biocon and Mylan are seeking approval from the US Food and Drug Administration (USFDA) for a biosimilar version of Roche’s cancer drug trastuzumab.
Production & Manufacturing > Manufacturing > News
FDA gives priority review status to Novartis’ breast cancer drug
By PBR Staff Writer
Pharma giant Novartis has secured the US Food and Drug Administration (FDA) Priority Review for its advanced breast cancer drug ribociclib (LEE011).
Production & Manufacturing > Manufacturing > News
Portola expands collaboration with Daiichi to develop AndexXa in Germany
Portola Pharmaceuticals (PTLA) has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop AndexXa (andexanet alfa) as an antidote for the former’s Factor Xa inhibitor named as edoxaban.
Production & Manufacturing > Manufacturing > News
Nimbus secures $200m from Gilead for inhibitor program acquisition
Nimbus Therapeutics secured a $200m from Gilead Sciences in a payment related to the latter’s allosteric Acetyl-CoA Carboxylase (ACC) inhibitor program with NDI-010976 (now GS-0976) which was previously acquired from Nimbus.
Production & Manufacturing > Manufacturing > News
Celgene and IBM Watson to develop new offering for patient safety monitoring
Celgene and IBM Watson Health will co-develop a new offering that aims to enhance pharmacovigilance methods used to collect, assess, monitor, and report adverse drug reactions.
Production & Manufacturing > Manufacturing > News
Valeant in talks to divest gastroenterology business unit
By PBR Staff Writer
Valeant Pharmaceuticals International is in talks with third parties to divest its various assets, including Salix gastroenterology business unit.
Production & Manufacturing > Manufacturing > News
46-60 of 2220 results